TEBALDI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 4.563
AS - Asia 2.858
EU - Europa 1.516
SA - Sud America 488
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 9.499
Nazione #
US - Stati Uniti d'America 4.460
SG - Singapore 1.173
CN - Cina 642
DE - Germania 386
BR - Brasile 382
VN - Vietnam 317
IT - Italia 251
HK - Hong Kong 245
FI - Finlandia 214
GB - Regno Unito 134
FR - Francia 121
UA - Ucraina 104
TR - Turchia 100
JP - Giappone 75
IN - India 73
SE - Svezia 71
RU - Federazione Russa 66
ID - Indonesia 57
PL - Polonia 53
MX - Messico 46
BD - Bangladesh 45
CA - Canada 42
NL - Olanda 35
AR - Argentina 32
ZA - Sudafrica 31
IQ - Iraq 27
EC - Ecuador 24
CO - Colombia 17
ES - Italia 17
AT - Austria 14
PH - Filippine 12
LT - Lituania 11
PK - Pakistan 11
BE - Belgio 10
VE - Venezuela 10
MY - Malesia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
KE - Kenya 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
MA - Marocco 6
IE - Irlanda 5
PE - Perù 5
UY - Uruguay 5
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
KR - Corea 4
KZ - Kazakistan 4
PY - Paraguay 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
AU - Australia 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GY - Guiana 2
HR - Croazia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MW - Malawi 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
Totale 9.490
Città #
Ashburn 731
Singapore 710
Fairfield 387
San Jose 328
Woodbridge 310
Munich 250
Hong Kong 241
Beijing 233
Santa Clara 230
Houston 189
Chandler 173
Helsinki 139
Seattle 138
Wilmington 127
Cambridge 122
Ho Chi Minh City 114
Jacksonville 113
Ann Arbor 105
Dallas 84
New York 84
Los Angeles 83
Tokyo 75
Hanoi 63
Princeton 61
Lauterbourg 54
Jakarta 52
Izmir 51
Council Bluffs 50
Shanghai 49
San Diego 47
São Paulo 47
Warsaw 47
Nanjing 40
Ferrara 39
Turku 38
Milan 37
London 36
Chicago 28
Mexico City 28
Brooklyn 27
Orem 25
Chennai 23
Buffalo 20
Bremen 19
Bologna 18
Frankfurt am Main 18
Boardman 17
Denver 17
Johannesburg 17
Stockholm 17
Atlanta 16
Boston 16
Haiphong 15
San Francisco 15
Montreal 14
Moscow 14
Tianjin 14
Nanchang 13
Nuremberg 13
Da Nang 12
Toronto 12
Amsterdam 11
Falls Church 11
Rio de Janeiro 11
Augusta 10
Brussels 10
Dong Ket 9
Jyväskylä 9
Lappeenranta 9
Salt Lake City 9
Ankara 8
Dhaka 8
Falkenstein 8
Jiaxing 8
Mumbai 8
Quito 8
Shenyang 8
Tashkent 8
Charlotte 7
Goiânia 7
Hebei 7
Hefei 7
Hải Dương 7
Kathmandu 7
Ninh Bình 7
Norwalk 7
Phoenix 7
The Dalles 7
Washington 7
Baghdad 6
Brasília 6
Campinas 6
Changsha 6
City of London 6
Des Moines 6
Hangzhou 6
Mountain View 6
Nairobi 6
Poplar 6
Redondo Beach 6
Totale 6.401
Nome #
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 414
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 282
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 276
Poor response to clopidogrel: current and future options for its management 269
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 234
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 228
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 216
Angina and left ventricular dysfunction: can we "reduce' it? 211
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 208
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 208
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 204
Fractional flow reserve: Current applications and overview of the available data 199
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 196
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 191
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 188
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 188
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 186
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 186
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 179
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 179
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 174
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 172
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 171
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 171
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 171
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 169
Fractional flow reserve implementation in daily clinical practice: A European survey 169
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 167
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 167
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 163
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 161
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 158
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 153
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 153
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 148
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 144
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 143
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 142
Enhanced stent visualization systems during PCI: A case series and review of literature 139
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 139
Functional Assessment and Acute Coronary Syndrome 132
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 129
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 125
Seven french radial artery access for PCI: A prospective single-center experience 123
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 115
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 113
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 112
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 107
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 103
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 102
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 99
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 96
null 94
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 89
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 85
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 84
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 80
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 80
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 74
Low FFR equal to low ischemia: Really? 60
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 53
Totale 9.671
Categoria #
all - tutte 48.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021224 0 0 0 0 0 0 0 0 0 90 87 47
2021/2022624 86 57 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/20251.981 25 36 130 82 206 219 164 137 369 176 254 183
2025/20264.120 446 213 388 498 662 266 474 239 497 437 0 0
Totale 9.671